SBRA
Sabra Health Care REIT, Inc. Real Estate - Healthcare Facilities Investor Relations →
Sabra Health Care REIT, Inc. (SBRA) closed at $20.36 as of 2026-05-01, trading 46.2% above its 200-week moving average of $13.93. The stock moved further from the line this week, up from 44.7% last week. The 14-week RSI sits at 66, indicating neutral momentum.
Trading volume is running at 1.5x of its 14-week average, which is in the normal range. The balance between buying and selling volume (1.05 ratio) is neutral — neither side is clearly dominating.
Over the past 1208 weeks of data, SBRA has crossed below its 200-week moving average 25 times. On average, these episodes lasted 20 weeks. Historically, investors who bought SBRA at the start of these episodes saw an average one-year return of +180.5%.
With a market cap of $5.1 billion, SBRA is a mid-cap stock. The company generates a free cash flow yield of 3.9%. Return on equity stands at 5.7%. The stock trades at 1.8x book value.
Share count has increased 9.0% over three years, indicating dilution.
Over the past 23.2 years, a hypothetical investment of $100 in SBRA would have grown to $16838, compared to $1298 for the S&P 500. That represents an annualized return of 24.8% vs 11.7% for the index — confirming SBRA as a market-beating investment and the kind of quality company where buying during 200-week moving average touches has historically been rewarded.
Free cash flow has been growing at a 3.4% compound annual rate, with 4 consecutive years of positive cash generation.
Business Health
Annual financials — how the underlying business has performed over the past several years.
Cash Flow Free cash flow & net income ($M)
Revenue Annual revenue ($M) — business growth proxy
Total Debt Balance sheet debt ($M)
ROIC Return on invested capital (%)
FCF Yield Free cash flow / market cap (%) — Yartseva signal
Gross Margin Pricing power & competitive moat (%)
Shares Outstanding Buybacks vs dilution (millions)
Growth of $100: SBRA vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After SBRA Crosses Below the Line?
Across 25 historical episodes, buying SBRA when it crossed below its 200-week moving average produced an average return of +297.8% after 12 months (median +14.0%), compared to +16.6% for the S&P 500 over the same periods. 56% of those episodes were profitable after one year. After 24 months, the average return was +200.5% vs +33.6% for the index.
Each line shows $100 invested at the moment SBRA crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Historical Touches
SBRA has crossed below its 200-week MA 25 times with an average 1-year return of +180.5% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| Mar 2003 | Sep 2003 | 26 | 98.4% | +4183.3% | +8318.9% |
| May 2004 | May 2004 | 1 | 9.2% | -7.3% | +277.5% |
| Jun 2004 | Jun 2004 | 1 | 2.1% | -14.6% | +248.4% |
| Jul 2004 | Aug 2004 | 4 | 8.6% | -8.7% | +271.4% |
| Oct 2004 | Nov 2004 | 2 | 1.1% | +8.6% | +241.3% |
| Nov 2004 | Dec 2004 | 4 | 5.6% | +4.2% | +257.7% |
| Feb 2005 | Oct 2005 | 34 | 19.3% | -15.3% | +236.8% |
| Nov 2005 | Nov 2005 | 1 | 0.3% | +47.1% | +243.2% |
| Dec 2005 | Mar 2006 | 12 | 15.7% | +73.3% | +268.7% |
| Oct 2008 | Oct 2008 | 1 | 1.7% | -12.6% | +129.0% |
| Nov 2008 | Feb 2009 | 12 | 24.0% | -20.1% | +134.9% |
| Feb 2009 | Jul 2012 | 177 | 63.0% | -0.6% | +182.5% |
| Sep 2015 | Oct 2015 | 1 | 0.0% | +22.2% | +115.7% |
| Oct 2015 | Jul 2016 | 38 | 32.3% | +10.5% | +113.4% |
| Oct 2016 | Nov 2016 | 4 | 9.9% | +1.2% | +116.9% |
| Aug 2017 | Aug 2017 | 3 | 7.4% | +13.2% | +96.3% |
| Sep 2017 | May 2018 | 34 | 21.6% | +16.2% | +88.7% |
| Nov 2018 | Nov 2018 | 2 | 5.3% | +28.7% | +101.3% |
| Dec 2018 | Jan 2019 | 5 | 14.2% | +19.7% | +96.2% |
| Feb 2019 | Mar 2019 | 3 | 5.6% | +20.1% | +102.7% |
| Mar 2020 | Nov 2020 | 36 | 50.5% | +87.5% | +215.1% |
| Aug 2021 | Aug 2021 | 1 | 3.8% | +13.2% | +94.0% |
| Sep 2021 | Jul 2022 | 43 | 22.8% | -4.4% | +92.6% |
| Sep 2022 | Jul 2023 | 44 | 22.7% | +6.1% | +93.6% |
| Jul 2023 | Aug 2023 | 4 | 6.4% | +40.4% | +95.8% |
| Average | 20 | — | +180.5% | — |
Frequently Asked Questions
Is SBRA below its 200-week moving average?
No. Sabra Health Care REIT, Inc. (SBRA) is currently 46.2% above its 200-week moving average of $13.93. It would need to fall to $13.93 to cross below the line.
What is SBRA's 200-week moving average price?
Sabra Health Care REIT, Inc.'s 200-week moving average is $13.93 as of 2026-05-01. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.
What happens when SBRA drops below its 200-week moving average?
SBRA has crossed below its 200-week moving average 25 times in our data. On average, buying at that moment produced a one-year return of +180.5%. These dips have historically been decent entry points. These episodes lasted 20 weeks on average.
Is SBRA a good value right now?
Here's what our data says about SBRA as of 2026-05-01: The stock is above its 200-week moving average, so it doesn't currently meet our primary signal. The 14-week RSI is 66. Free cash flow yield is 3.9%. Return on equity is 5.7%. Price-to-book is 1.8x. This is not a buy or sell recommendation — always do your own research.
How does SBRA compare to the S&P 500?
Over the past 23.2 years, $100 invested in SBRA would have grown to $16838, compared to $1298 for the S&P 500. That's 24.8% annualized vs 11.7% for the index. SBRA has outperformed the broader market over this period.
Does SBRA pay a dividend?
Yes. Sabra Health Care REIT, Inc. currently pays a dividend yield of 590.00%.
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of week of 2026-05-01